US Animal Drug Compounding Market is segmented by CNS Agents, Anti-Infective Agents, Hormones and Substitutes, Anti-inflammatory Agents, Oral, Injectable
Industry: Healthcare
Published Date: August-2019
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 79
Report ID: PMRREP30058
1. Executive Summary
1.1. U.S. Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Macro-Economic Factors
3.2. Forecast Factors - Relevance & Impact
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints
3.4. Opportunity Analysis
4. Market Context
4.1. Animal Healthcare Spending
4.2. Regulatory Scenario by FDA
4.3. 503A vs 503B Pharmacy Analysis
5. U.S. Animal Drug Compounding Market Value Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. U.S. Animal Drug Compounding Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014-2018
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 - 2029
6.3.1. CNS Agents
6.3.2. Anti-Infective Agents
6.3.3. Hormones and Substitutes
6.3.4. Anti-inflammatory Agents
6.3.5. Others
6.4. Market Attractiveness Analysis By Product Type
7. U.S. Animal Drug Compounding Market Analysis 2014-2018 and Forecast 2019-2029, by Pharmacy Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Pharmacy Type, 2014-2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Pharmacy Type, 2019 - 2029
7.3.1. 503A Pharmacy (In-house Veterinary Pharmacy)
7.3.2. 503B Pharmacy (Outsourcing Pharmacy)
7.4. Market Attractiveness Analysis By Pharmacy Type
8. U.S. Animal Drug Compounding Market Analysis 2014-2018 and Forecast 2019-2029, by Formulation
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Formulation Type, 2014-2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Formulation, 2019 - 2029
8.3.1. Oral
8.3.2. Injectable
8.3.3. Others
8.4. Market Attractiveness Analysis By Formulation
9. U.S. Animal Drug Compounding Market Analysis 2014-2018 and Forecast 2019-2029, by Animal Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Animal Type, 2014-2018
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Animal Type, 2019 - 2029
9.3.1. Companion Animals
9.3.1.1. Dogs
9.3.1.2. Cats
9.3.1.3. Others
9.3.2. Livestock Animals
9.4. Market Attractiveness Analysis By Animal Type
10. Competition Analysis
10.1. Competition Dashboard
10.2. Competition Deep Dive
10.2.1. Hoye's Pharmacy
10.2.1.1. Company Overview
10.2.1.2. Analyst Commentary
10.2.1.3. Product Offering
10.2.2. Vertisis Custom Pharmacy
10.2.2.1. Company Overview
10.2.2.2. Analyst Commentary
10.2.2.3. Product Offering
10.2.3. Smith Caldwell Drug Store
10.2.3.1. Company Overview
10.2.3.2. Analyst Commentary
10.2.3.3. Product Offering
10.2.4. Sixth Avenue Medical Pharmacy
10.2.4.1. Company Overview
10.2.4.2. Analyst Commentary
10.2.4.3. Product Offering
10.2.5. Dougherty's Pharmacy
10.2.5.1. Company Overview
10.2.5.2. Analyst Commentary
10.2.5.3. Product Offering
10.2.6. Triangle Compounding Pharmacy Inc.
10.2.6.1. Company Overview
10.2.6.2. Analyst Commentary
10.2.6.3. Product Offering
10.2.7. Medisca Inc.
10.2.7.1. Company Overview
10.2.7.2. Analyst Commentary
10.2.7.3. Product Offering
10.2.8. Wedgewood Pharmacy
10.2.8.1. Company Overview
10.2.8.2. Analyst Commentary
10.2.8.3. Product Offering
10.2.9. Millers Pharmacy
10.2.9.1. Company Overview
10.2.9.2. Analyst Commentary
10.2.9.3. Product Offering
11. Assumptions and Acronyms Used
12. Research Methodology
Table 01: 503A and 503B Pharmacy Comparative Analysis
Table 02: U.S. Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Product Type
Table 03: U.S. Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Pharmacy Type
Table 04: U.S. Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Animal Type
Table 05: U.S. Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Formulation
Figure 01: U.S. Animal Drug Compounding Market Value (US$ Mn) by Product Type, 2019 & 2029
Figure 02: U.S. Pet Industry Expenditures (US$ Bn), 2001-2019
Figure 03: Breakdown of Pet Expenditures in U.S., 2018
Figure 04: U.S. Animal Drug Compounding Market Value Analysis (US$ Mn), 2014-2018
Figure 05: U.S. Animal Drug Compounding Market Value Forecast (US$ Mn), 2019-2029
Figure 06: U.S. Animal Drug Compounding Market Absolute $ Opportunity, 2019–2029
Figure 07: U.S. Animal Drug Compounding Market Value Share Analysis (%), By Product Type, 2019 (E)
Figure 08: U.S. Animal Drug Compounding Market Y-o-Y Analysis (%), By Product Type, 2019-2029
Figure 09: U.S. Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, Product Type
Figure 10: U.S. Animal Drug Compounding Market Attractiveness Analysis by Product Type, 2019-2029
Figure 11: U.S. Animal Drug Compounding Market Value Share Analysis (%), By Pharmacy Type, 2019 (E)
Figure 12: U.S. Animal Drug Compounding Market Y-o-Y Analysis (%), By Pharmacy Type, 2019-2029
Figure 13: U.S. Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, Pharmacy Type
Figure 14: U.S. Animal Drug Compounding Market Attractiveness Analysis by Pharmacy Type, 2019-2029
Figure 15: U.S. Animal Drug Compounding Market Value Share Analysis (%), By Animal Type, 2019 (E)
Figure 16: U.S. Animal Drug Compounding Market Y-o-Y Analysis (%), By Animal Type, 2019-2029
Figure 17: U.S. Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, Animal Type
Figure 18: U.S. Animal Drug Compounding Market Attractiveness Analysis by Animal Type, 2019-2029
Figure 19: U.S. Animal Drug Compounding Market Value Share Analysis (%), By Formulation, 2019 (E)
Figure 20: U.S. Animal Drug Compounding Market Y-o-Y Analysis (%), By Formulation, 2019-2029
Figure 21: U.S. Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, Formulation
Figure 22: U.S. Animal Drug Compounding Market Attractiveness Analysis by Formulation, 2019-2029